LANXESS (XTRA:LXS) has put its new tire additive Vulkanox 4060 in the spotlight after securing EU REACH registration. The company is positioning the compound as an environmentally oriented alternative to 6PPD for European producers.
LANXESS shares trade at €15.46, with a 1-day share price return of 1.05% and a 7-day share price return of 2.86%, yet the year-to-date share price return is down 11.76% and the 1-year total shareholder return has declined 33.38%, pointing to fading long-term momentum despite pockets of short-term optimism around developments such as Vulkanox 4060.
Compare LANXESS with other specialty chemicals players preparing for tighter environmental rules by scanning our hand picked list of solid balance sheet and fundamentals (193 results).
LANXESS now combines a new product story with a share price that has declined significantly over one-year and five-year periods. Do you take advantage of the weakness today, or wait to see what future numbers indicate about a potentially better entry point?
At €15.46, the most followed narrative for LANXESS points to a fair value of €17.91, which frames today’s price as a meaningful discount and puts the focus firmly on what needs to go right in the next few years.
Ongoing portfolio and network optimization, digitalization efforts (including use of AI for efficiency gains), and an enhanced focus on cost containment are expected to deliver further operating leverage, thus improving free cash flow and ROIC even before market conditions materially improve.
Read the complete narrative. Read the complete narrative.
Curious what earnings power LANXESS would need to reach that fair value, how fast revenue is assumed to build, and which margin reset underpins the projected future multiple?
Result: Fair Value of €17.91 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
Still, the LANXESS narrative can break if high energy costs in Europe keep eroding competitiveness, or if weak demand in key end markets lingers longer than expected.
Find out about the key risks to this LANXESS narrative.
Mixed messages so far on LANXESS, with a discounted fair value story sitting beside real operational risks that investors are watching closely. If you want to move quickly and form your own view, start by weighing the company specific concerns against the potential upside highlighted in our 2 key rewards and 1 important warning sign.
If LANXESS has sharpened your focus on valuation, risk, and balance sheet quality, do not stop here. Broaden your opportunity set with targeted screeners that surface companies matching your preferred profile before the crowd notices.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com